Revolution Medicines, Inc. (NASDAQ:RVMDW) Shares Shorted: Short Interest Up 106.3% in October

Revolution Medicines, Inc. (NASDAQ:RVMDW) saw a large growth in short interest in October. As of October 15th, there was short interest totaling 1,578 shares, a growth of 106.3% from the September 30th total of 765 shares. Based on an average daily volume of 19,075 shares, the short-interest ratio is presently 0.1 days.

Revolution Medicines Trading Up 1.8%

Shares of NASDAQ:RVMDW traded up $0.17 during trading hours on Friday, reaching $9.81. The stock had a trading volume of 5,614 shares, compared to its average volume of 94,843. The firm’s 50 day moving average is $10.69 and its 200-day moving average is $6.63. Revolution Medicines has a 1 year low of $0.34 and a 1 year high of $13.44.

About Revolution Medicines

Revolution Medicines, Inc is a clinical-stage biopharmaceutical company focused on developing targeted therapies for patients with cancer. The company’s research is centered on the RAS signaling pathway, which is frequently altered in tumors and has historically been difficult to target with medicines.

Revolution Medicines is developing a pipeline of RAS(ON) inhibitors designed to block active RAS proteins and related signaling. Its investigational programs include daraxonrasib (RMC-6236), an oral, broad-spectrum RAS(ON) inhibitor, as well as mutation-selective candidates such as RMC-9805 for KRAS G12D and RMC-6291 for KRAS G12C.